Analytical Data
-
Gene name
IGLL5
- Application
-
Alternative Names
G lambda-1 Germline immunoglobulin lambda 1
-
Species
Human
-
Source
Yeast
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
B9A064
-
Expression Region
36-214aa
-
Molecular Weight
21.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IGLL5, or Immunoglobulin Lambda-Like Polypeptide 5, is a protein that plays a critical role in the immune system, particularly in the development of B cells and the production of antibodies. Research has shown that IGLL5 is primarily expressed in B-cell precursors and is implicated in immunological functions, including the regulation of immune responses and the maintenance of B cell homeostasis. Given its significance in B cell maturation and function, aberrations in IGLL5 expression have been associated with various immune-related disorders, including autoimmunity and lymphoproliferative diseases. The study of recombinant IGLL5 protein offers valuable insights into its structural and functional properties, enabling researchers to explore its specific mechanisms in immune modulation. Understanding the role of IGLL5 at a molecular level may pave the way for the development of novel therapeutic strategies targeting immune dysfunctions. Furthermore, recombinant protein production techniques facilitate the generation of large quantities of IGLL5, allowing for detailed biochemical and biophysical characterization, functional assays, and potential applications in clinical settings, such as vaccine development or treatment of immune disorders. Overall, IGLL5 represents a promising subject of research within immunology, providing opportunities to deepen our understanding of immune regulation and the potential for therapeutic interventions.
